A novel protein export chaperone of Mycobacterium tuberculosis
结核分枝杆菌的新型蛋白质输出伴侣
基本信息
- 批准号:9892319
- 负责人:
- 金额:$ 59.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-03 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AntigensAntitubercular AgentsAttenuated Live Virus VaccineBacterial PhysiologyBacterial ProteinsBinding SitesBiochemicalBiochemical GeneticsBiologyCategoriesCessation of lifeComplexCrystallizationCytoplasmDataDevelopmentEngineeringEnvironmentEpidemicExhibitsFutureGenetic StructuresGenus MycobacteriumGoalsGrowthHealthHydrophobicityImmune responseInfectionInterdisciplinary StudyKnowledgeLabelLaboratoriesLeadLengthLipidsMeasuresMolecularMolecular BiologyMolecular ChaperonesMycobacterium tuberculosisPathogenesisPathway interactionsPeptidesPhagosomesPhosphoric Monoester HydrolasesPlayProtein Export PathwayProteinsProteomicsResearch PersonnelRoentgen RaysRoleStructureSubstrate SpecificityTestingTuberculosisVirulenceWorld Healthbiological systemsbiophysical analysiscell envelopedrug developmentextracellularimprovedmacrophagemycobacterialnovelnovel strategiesnovel therapeuticspathogenic bacteriapreventstoichiometrytooltuberculosis treatmentvaccine development
项目摘要
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), represents a severe world health
crisis (4,000 TB deaths daily). A better understanding of Mtb biology and pathogenesis will drive development
of novel strategies to control the TB epidemic. In bacterial pathogens, like Mtb, many proteins are exported to
the bacterial cell envelope or the extracellular environment in order to carry out critical functions in bacterial
physiology, virulence or immune responses. Thus, Mtb pathways that export proteins could be targeted or
exploited for the development of novel anti-TB control measures. However, significant gaps exist in our
understanding of Mtb protein export.
This proposal is to determine the mechanism of SatS, a novel protein export chaperone we discovered
in Mtb. SatS is a chaperone for a subset of proteins that are exported by the specialized SecA2 protein export
pathway, and SatS is required for intracellular growth of Mtb in macrophages. However, SatS shares no
sequence or structural similarity with any previously characterized proteins and the mechanism of SatS is
completely unknown. Substrate specificity and the scope of SatS substrates are also unknown. Aim 1 of this
proposal is to determine the mechanistic details of SatS function in protein export. Aim 2 is to determine the
structures of SatS and that of SatS in complex with peptides of substrates. Aim 3 is to identify SatS-binding
sites in substrates and to identify additional SatS substrates. By completing these Aims, we will determine the
mechanism and contribution of SatS to Mtb protein export and biology. More broadly, these studies will
improve our understanding of bacterial strategies for exporting proteins and of the diversity of molecular
chaperones across biological systems. Long-term, the results could lead to strategies for inhibiting protein
export as a novel anti-TB therapy. Alternatively, the knowledge gained could be harnessed to engineer
mycobacterial strains with improved capacity to export proteins for use as experimental tools or as live,
attenuated vaccines with enhanced antigen export.
结核分枝杆菌(MTB),结核病的病因(TB)代表严重的世界健康
危机(每天4,000 TB死亡)。更好地了解MTB生物学和发病机理将推动发展
控制结核病流行的新型策略。在细菌病原体(如MTB)中,许多蛋白质被导出到
为了在细菌中执行关键功能,细菌细胞包膜或细胞外环境
生理,毒力或免疫反应。因此,可以针对导出蛋白的MTB途径或
利用用于开发新型抗TB控制措施。但是,我们的
了解MTB蛋白出口。
该建议是确定SAT的机制,SATS是一种新型的蛋白质导出伴侣,我们发现了
在MTB中。 SATS是由专门的SECA2蛋白导出的蛋白质子集的伴侣
途径和SAT是巨噬细胞中MTB细胞内生长所必需的。但是,SATS no
序列或结构性相似性与任何先前表征的蛋白质以及SAT的机制是
完全未知。底物特异性和SATS底物的范围也未知。目标1
建议是确定蛋白质导出中SATS功能的机械细节。目标2是确定
SATS的结构和与底物肽的复杂性。 AIM 3是确定SATS结合
基板中的站点并识别其他SATS基板。通过完成这些目标,我们将确定
SATS对MTB蛋白出口和生物学的机制和贡献。更广泛地,这些研究将
提高我们对导出蛋白质和分子多样性的细菌策略的理解
跨生物系统的伴侣。长期,结果可能导致抑制蛋白质的策略
出口作为一种新型的抗TB疗法。另外,获得的知识可能会被利用
分枝杆菌菌株具有提高导出蛋白的能力以用作实验工具的能力或实时菌株
抗原出口增强的疫苗减弱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miriam S. Braunstein其他文献
Miriam S. Braunstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miriam S. Braunstein', 18)}}的其他基金
Effect of Microenvironment on the Activity of Mycobacteriophages for Treating Mycobacterium abscessus
微环境对治疗脓肿分枝杆菌噬菌体活性的影响
- 批准号:
10287665 - 财政年份:2021
- 资助金额:
$ 59.87万 - 项目类别:
Effect of Microenvironment on the Activity of Mycobacteriophages for Treating Mycobacterium abscessus
微环境对治疗脓肿分枝杆菌噬菌体活性的影响
- 批准号:
10454361 - 财政年份:2021
- 资助金额:
$ 59.87万 - 项目类别:
A novel protein export chaperone of Mycobacterium tuberculosis
结核分枝杆菌的新型蛋白质输出伴侣
- 批准号:
10079468 - 财政年份:2020
- 资助金额:
$ 59.87万 - 项目类别:
A novel protein export chaperone of Mycobacterium tuberculosis
结核分枝杆菌的新型蛋白质输出伴侣
- 批准号:
10541104 - 财政年份:2020
- 资助金额:
$ 59.87万 - 项目类别:
A novel protein export chaperone of Mycobacterium tuberculosis
结核分枝杆菌的新型蛋白质输出伴侣
- 批准号:
10312020 - 财政年份:2020
- 资助金额:
$ 59.87万 - 项目类别:
Aerosol spectinamide-1599 therapy against tuberculosis
壮观酰胺-1599气雾剂治疗结核病
- 批准号:
9196248 - 财政年份:2016
- 资助金额:
$ 59.87万 - 项目类别:
Targeting SecA1 of Mycobacterium tuberculosis for Novel Drug Development
靶向结核分枝杆菌 SecA1 的新药开发
- 批准号:
8703436 - 财政年份:2014
- 资助金额:
$ 59.87万 - 项目类别:
Developing High-Throughput Assays for M. tuberculosis Tat Pathway Inhibitors
开发结核分枝杆菌 Tat 通路抑制剂的高通量检测方法
- 批准号:
8606395 - 财政年份:2012
- 资助金额:
$ 59.87万 - 项目类别:
Developing High-Throughput Assays for M. tuberculosis Tat Pathway Inhibitors
开发结核分枝杆菌 Tat 通路抑制剂的高通量检测方法
- 批准号:
8434858 - 财政年份:2012
- 资助金额:
$ 59.87万 - 项目类别:
相似国自然基金
L12与L10蛋白相互作用作为新型抗结核药物分子靶标的研究及其阻断剂的筛选
- 批准号:81001461
- 批准年份:2010
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
抗结核特异抗体靶向造影剂对免疫缺陷性结核病诊断的动物实验研究
- 批准号:81071153
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)
确定儿童未来结核病进展风险的相关性 (INTREPID)
- 批准号:
10637036 - 财政年份:2023
- 资助金额:
$ 59.87万 - 项目类别:
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 59.87万 - 项目类别:
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
- 批准号:
10698829 - 财政年份:2023
- 资助金额:
$ 59.87万 - 项目类别:
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood
血液中无细胞结核分枝杆菌 DNA 及其耐药变异体的多重检测
- 批准号:
10639855 - 财政年份:2023
- 资助金额:
$ 59.87万 - 项目类别:
Innovating anti-tuberculosis drug susceptibility testing with a novel and rapid non-culture based phenotypic test using MPT64 biomarker
使用 MPT64 生物标志物,通过新型、快速的非培养表型测试来创新抗结核药物敏感性测试
- 批准号:
10663034 - 财政年份:2023
- 资助金额:
$ 59.87万 - 项目类别: